< Back to previous page
Researcher
Eric Legius
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurofibromatosis Research (Division)
Member
From15 Jul 2022 → Today - Department of Human Genetics (Department)
Member
From1 Oct 1999 → 14 Jul 2022
Projects
1 - 10 of 19
- Monogenic immune disorders in adults: from Mendelian inheritance to somatic mosaicismFrom3 Oct 2022 → TodayFunding: FWO fellowships
- Importance of SPRED1 in melanomaFrom9 Dec 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- EU Patient- cEntric clinicAl tRial pLatformFrom1 Nov 2019 → 30 Apr 2023Funding: H2020 - European Institute of Innovation and Technology
- The effect of genetic factors on the severity of the ASD phenotypeFrom1 Sep 2018 → 1 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Importance of SPRED1 in melanomaFrom1 Jan 2017 → 30 Jun 2021Funding: Other federal scientific institutions
- Unraveling the genetics of familial SchwannomatosisFrom1 Oct 2016 → 30 Sep 2017Funding: Nonprofit institution or equivalents
- Importance of SPRED1 in melanomaFrom1 Oct 2015 → 27 Mar 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Periosteal cell therapy as a new treatment of pseudarthrosis in children with NF1.From21 Oct 2013 → 10 Dec 2019Funding: IWT personal funding - strategic basic research grants, BOF - Doctoral projects
- A molecular approach to understand breast cancer cell dormancy.From1 Oct 2012 → 4 Jul 2019Funding: FWO fellowships
- Pathogenesis of congenital tibial bowing and pseudarthrosis in neurofibromatosis type 1.From1 Jan 2012 → 31 Dec 2015Funding: FWO research project
Publications
41 - 50 of 214
- Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies(2020)
Authors: Eric Legius
Pages: 866 - 876 - Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies(2020)
Authors: Eric Legius
Pages: 866 - 876 - Legius Syndrome and its Relationship with Neurofibromatosis Type 1(2020)
Authors: Ellen Denayer, Eric Legius
Pages: 161 - 167 - Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple cafe-au-lait macules(2020)
Authors: Hilde Brems, Eric Legius
Pages: 264 - 275 - Multidisciplinary Approach to Neurofibromatosis Type 1(2020)
Authors: Gianluca Tadini, Eric Legius, Hilde Brems
- Risk-reducing mastectomy in BRCA carriers: survival is not the issue(2020)
Authors: Patrick Neven, Kevin Punie, Hans Wildiers, Chantal Van Ongeval, Griet Van Buggenhout, Eric Legius
Pages: 251 - 252 - Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1(2020)
Authors: Eric Legius
Pages: 299 - 315 - NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation(2020)
Authors: Hilde Brems, Eric Legius
Pages: 157 - 174 - Neurofibromatosis type 1-related pseudarthrosis(2019)
Authors: Carlijn Brekelmans, Eric Legius, Hilde Brems, Johan Lammens
- Maternal copy-number variations in the DMD gene as secondary findings in noninvasive prenatal screening(2019)
Authors: Nathalie Brison, Kristl Claeys, Thomy de Ravel de l'Argentière, Liesbeth De Waele, Nathalie Goemans, Eric Legius, Hilde Peeters, Hilde Van Esch, Joris Vermeesch, Koenraad Devriendt, et al.
Pages: 2774 - 2780